Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;6(2):88-92.
doi: 10.1177/2040620714566567.

Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine?

Smith Giri  1 , Vijaya Raj Bhatt  2 , Sumesh Khanal  3 , Apar Kishor Ganti  4
Affiliations

Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine?

Smith Giri et al. Ther Adv Hematol. 2015 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: AKG reports serving as a consultant for Boehringer Ingelheim and Otsuka Pharmaceuticals. There are no conflict of interest for any other authors.

References

    1. Astrow A. (2003) Fludarabine-related myeloid leukemia. J Clin Oncol 21: 3709–3710. - PubMed
    1. Bracey A., Maddox A., Immken L., Hsu S., Marks M. (1989) Coexistence of myelodysplastic syndrome and untreated chronic lymphocytic leukemia with development of acute myeloid leukemia immediately after treatment of chronic lymphocytic leukemia. Am J Hematol 30: 174–180. - PubMed
    1. Cheson B., Friedberg J., Kahl B., Van Der Jagt R., Tremmel L. (2010) Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk 10: 452–457. - PubMed
    1. Cheson B., Vena D., Barrett J., Freidlin B. (1999) Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 17: 2454–2460. - PubMed
    1. Frederiksen H., Farkas D., Christiansen C., Hasselbalch H., Sorensen H. (2011) Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood 118: 6515–6520. - PubMed

LinkOut - more resources